Although these tumors had the same morphology, phenotype, cytogenetic characteristics, clonal relationship and MYD88 L265P mutations, the relapsed tumor had a distinct CD79B Y196S mutation, suggesting that both tumors might have evolved from a common progenitor clone with MYD88 L265P mutations. Here, MYD88 is linked to neoplasm.